Munich - Delayed Quote EUR

Iovance Biotherapeutics Inc (2LB.MU)

1.7596
+0.1952
+(12.48%)
At close: 8:00:52 AM GMT+2
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
212,679
164,070
1,189
0
0
Cost of Revenue
166,475
123,995
10,755
0
0
Gross Profit
46,204
40,075
-9,566
0
0
Operating Expense
444,981
435,353
450,993
398,878
342,703
Operating Income
-398,777
-395,278
-460,559
-398,878
-342,703
Net Non Operating Interest Income Expense
20,155
20,273
13,043
2,985
451
Pretax Income
-378,622
-375,005
-447,516
-395,893
-342,252
Tax Provision
-3,258
-2,828
-3,479
0
0
Net Income Common Stockholders
-375,364
-372,177
-444,037
-395,893
-342,252
Diluted NI Available to Com Stockholders
-375,364
-372,177
-444,037
-395,893
-342,252
Basic EPS
-1.22
-1.28
-1.89
-2.49
-2.23
Diluted EPS
-1.22
-1.28
-1.89
-2.49
-2.23
Basic Average Shares
304,039
289,877
235,131
159,259
153,406
Diluted Average Shares
304,039
289,877
235,131
159,259
153,406
Total Operating Income as Reported
-398,777
-395,278
-460,559
-398,878
-342,703
Total Expenses
611,456
559,348
461,748
398,878
342,703
Net Income from Continuing & Discontinued Operation
-375,364
-372,177
-444,037
-395,893
-342,252
Normalized Income
-375,364
-372,177
-444,037
-395,893
-342,252
Interest Income
20,155
20,273
13,043
2,985
451
Net Interest Income
20,155
20,273
13,043
2,985
451
EBIT
-398,777
-395,278
-460,559
-398,878
-342,703
EBITDA
-354,013
-351,672
-427,432
-377,743
-328,723
Reconciled Cost of Revenue
166,475
123,995
10,755
0
0
Reconciled Depreciation
44,764
43,606
33,127
21,135
13,980
Net Income from Continuing Operation Net Minority Interest
-375,364
-372,177
-444,037
-395,893
-342,252
Normalized EBITDA
-354,013
-351,672
-427,432
-377,743
-328,723
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 11/17/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

NXOA.BE Nicox SA
0.2275
+0.66%
 
5CV.HA CureVac NV
3.8920
+2.10%
 
ABRT.CN Albert Labs International Corp.
0.0050
0.00%
 
BT1.BE Bone Therapeutics SA
0.0021
+16.67%
 
P0F.F Egetis Therapeutics AB (publ)
0.3690
+12.33%
 
300759.SZ Pharmaron Beijing Co., Ltd.
24.51
+2.98%
 
AYJ.HA Valneva SE
2.6780
-1.69%
 
ALINT.PA IntegraGen SA
0.5200
-0.38%
 
AB3A.MU Sarepta Therapeutics Inc
35.20
-6.11%
 
W1H.MU Onco-Innovations Ltd
0.9825
+2.34%